News | December 19, 2025
JHS Svendgaard to invest Rs. 25 crore on building new manufacturing unit
The new facility is expected to generate 500-600 new jobs in the region
The new facility is expected to generate 500-600 new jobs in the region
Qfitlia is the first antithrombin (AT)-lowering therapy approved for routine prophylaxis in hemophilia
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
Glenmark's Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial is bioequivalent and therapeutically equivalent to the reference listed drug
The new centre brings advanced corneal procedures pioneered in India
Roche says its new assay “resolves this challenge by delivering accurate and specific results
Golcadomide, a CELMoD agent, continued to deliver deep and durable responses in aggressive B-cell and follicular lymphomas
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Columvi combined with gemcitabine and oxaliplatin dramatically extends survival in people with relapsed or refractory diffuse large B-cell lymphoma
HYMPAVZI’s safety profile was generally favorable
Subscribe To Our Newsletter & Stay Updated
